As Tau lesions from transgenic mouse models differ from pathological Tau deposits found in human brains, we further tested 14 of the 16 phospho-Tau antibodies in FFPE human brains sections from patients diagnosed with advanced-stage AD, PSP or PiD (Supp. This evidence concerns the gene MAPT and Alzheimer disease.